This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.
Both are investigational and neither is FDA-approved. Human clinical evidence specific to the combination is limited. They are commonly sold as research chemicals.
What they are
Both are growth-hormone secretagogues — they act on the body's own machinery for releasing growth hormone (GH) instead of injecting GH itself.
- CJC-1295 is a synthetic analogue of growth-hormone-releasing hormone (GHRH), engineered for a longer half-life (it binds albumin in the blood).
- Ipamorelin is a pentapeptide that mimics ghrelin, triggering GH release with a relatively selective action — sources note it tends not to strongly affect hormones like cortisol.
How they work
They're often paired because they hit two different receptor systems that both end in GH release. Acting through complementary pathways at once may, in theory, produce a more natural GH pulse than either alone. That's the rationale you'll see repeated — but note it's mechanistic reasoning, not proof of a specific clinical outcome.
The evidence
The individual peptides have some documented pharmacology, but human clinical evidence for the popular combination is limited. Sources generally describe the class's tolerability as more favorable than injecting synthetic HGH, particularly around IGF-1 overshoot and glucose dysregulation — but “more favorable than HGH” is a low bar and not the same as established efficacy for the goals people chase.
Safety
Commonly reported effects tie to GH stimulation — water retention, tingling/numbness, changes in appetite (ipamorelin mimics ghrelin), and injection-site reactions. Anything that raises GH/IGF-1 signaling warrants caution and, ideally, clinical oversight, especially given unknown long-term effects and the theoretical concerns around stimulating growth pathways.
Manipulating growth-hormone pathways is not trivial. The relatively favorable side-effect reports don't erase the fact that long-term data are lacking and these are unapproved compounds.
Regulatory status
Investigational; not FDA-approved; sold as research chemicals. Growth-hormone secretagogues are also prohibited in sport by WADA.
FAQ
QWhy combine them?
They stimulate GH release through two different pathways (GHRH-like and ghrelin-like), so pairing them is thought to produce a stronger, more natural pulse. It's a mechanistic rationale, not a proven-superior protocol.
QIs this the same as taking HGH?
No — these prompt your body to release its own GH, whereas HGH supplies it directly. Sources suggest the secretagogue approach has a somewhat more favorable side-effect profile, but it's still unapproved and under-studied.
QDoes ipamorelin cause hunger?
Because it mimics ghrelin (the 'hunger hormone'), appetite changes are commonly reported.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
- CJC-1295 + Ipamorelin: benefits, safety & buying advice (Innerbody)
- Ipamorelin & CJC-1295: clinical overview (Empire Medical Training)
- Safety and efficacy of ipamorelin and CJC-1295 (Dr.Oracle review)
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Questions & comments
No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.